BOD SCIENCE LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.024 AUD | -7.69% |
|
-.--% | -.--% |
| Mar. 25 | Bod Science Announces Delay in Appendix 4D Lodgement | MT |
| 2023 | BOD Science Signs Supply Agreement in Medicinal Cannabis with Green Farmers | MT |
Valuation
| Fiscal Period: June | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Capitalization 1 | 30.47 | 23.59 | 24.67 | 35.48 | 7.414 | 10.57 |
| Enterprise Value (EV) 1 | 27.36 | 20.75 | 18.28 | 27.43 | 3.748 | 9.504 |
| P/E ratio | -7.52 x | -2.93 x | -5 x | -7.86 x | -1.37 x | -1.23 x |
| Yield | - | - | - | - | - | - |
| Capitalization / Revenue | 26 x | 18.5 x | 4.16 x | 4.78 x | 1.46 x | 3.18 x |
| EV / Revenue | 23.4 x | 16.3 x | 3.09 x | 3.7 x | 0.74 x | 2.86 x |
| EV / EBITDA | -7.51 x | -2.72 x | -3.76 x | -6.4 x | -0.68 x | -1.19 x |
| EV / FCF | -16.4 x | -5.46 x | -8.74 x | -6.82 x | -1.47 x | -2.72 x |
| FCF Yield | -6.08% | -18.3% | -11.4% | -14.7% | -68.1% | -36.7% |
| Price to Book | 11.6 x | 11.4 x | 5.13 x | 4.1 x | 2.14 x | -15 x |
| Nbr of stocks (in thousands) | 56,432 | 69,390 | 91,369 | 105,915 | 105,915 | 153,212 |
| Reference price 2 | 0.5400 | 0.3400 | 0.2700 | 0.3350 | 0.0700 | 0.0690 |
| Announcement Date | 8/31/18 | 8/30/19 | 8/20/20 | 8/22/21 | 8/29/22 | 8/30/23 |
1AUD in Million2AUD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: June | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net sales 1 | 1.17 | 1.273 | 5.925 | 7.42 | 5.086 | 3.321 |
| EBITDA 1 | -3.642 | -7.631 | -4.859 | -4.283 | -5.545 | -7.983 |
| EBIT 1 | -3.672 | -7.695 | -4.904 | -4.332 | -5.602 | -8.038 |
| Operating Margin | -313.8% | -604.26% | -82.76% | -58.39% | -110.15% | -242.02% |
| Earnings before Tax (EBT) 1 | -3.672 | -7.624 | -4.819 | -4.226 | -5.407 | -7.953 |
| Net income 1 | -3.672 | -7.624 | -4.819 | -4.226 | -5.407 | -7.953 |
| Net margin | -313.8% | -598.68% | -81.33% | -56.96% | -106.31% | -239.47% |
| EPS 2 | -0.0718 | -0.1159 | -0.0540 | -0.0426 | -0.0510 | -0.0563 |
| Free Cash Flow 1 | -1.664 | -3.803 | -2.092 | -4.021 | -2.554 | -3.49 |
| FCF margin | -142.16% | -298.66% | -35.31% | -54.2% | -50.22% | -105.09% |
| FCF Conversion (EBITDA) | - | - | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - | - | - |
| Dividend per Share | - | - | - | - | - | - |
| Announcement Date | 8/31/18 | 8/30/19 | 8/20/20 | 8/22/21 | 8/29/22 | 8/30/23 |
1AUD in Million2AUD
Estimates
Balance Sheet Analysis
| Fiscal Period: June | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net Debt 1 | - | - | - | - | - | - |
| Net Cash position 1 | 3.12 | 2.84 | 6.39 | 8.05 | 3.67 | 1.07 |
| Leverage (Debt/EBITDA) | - | - | - | - | - | - |
| Free Cash Flow 1 | -1.66 | -3.8 | -2.09 | -4.02 | -2.55 | -3.49 |
| ROE (net income / shareholders' equity) | -131% | -325% | -140% | -62.8% | -89.2% | -576% |
| ROA (Net income/ Total Assets) | -61.7% | -131% | -49.4% | -28.1% | -44.7% | -114% |
| Assets 1 | 5.95 | 5.803 | 9.753 | 15.03 | 12.1 | 6.98 |
| Book Value Per Share 2 | 0.0500 | 0.0300 | 0.0500 | 0.0800 | 0.0300 | -0 |
| Cash Flow per Share 2 | 0.0600 | 0.0400 | 0.0700 | 0.0800 | 0.0300 | 0.0100 |
| Capex 1 | 0.05 | 0.06 | 0.02 | 0.02 | 0.02 | 0.07 |
| Capex / Sales | 4% | 4.99% | 0.36% | 0.25% | 0.38% | 2.09% |
| Announcement Date | 8/31/18 | 8/30/19 | 8/20/20 | 8/22/21 | 8/29/22 | 8/30/23 |
1AUD in Million2AUD
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
| 1st Jan change | Capi. | |
|---|---|---|
| -.--% | 2.78M | |
| +23.05% | 3.66B | |
| +109.78% | 2B | |
| +87.30% | 61.69M |
- Stock Market
- Equities
- BOD Stock
- Financials Bod Science Limited
